Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inovio Pharmaceuticals Inc.

www.inovio.com

Latest From Inovio Pharmaceuticals Inc.

Stockwatch: Reading The Entrails Of Biotech Vaccine Development

As generalist investors continue to push higher the stock prices of biotech companies that announce the most tenuous of coronavirus developments, the track record of biotech companies developing even vaccines for which the antigen is proven to be safe and efficacious remains poor.

Stockwatch Vaccines

Coronavirus Update: AZ Gets $1bn From US, Secures Capacity For One Billion Vaccine Doses

Inovio vaccine data published, US government invests to protect, generic remdesivir launched in Bangladesh.

Companies Coronavirus COVID-19

China Still Leading Vaccines Race Despite Moderna Data, US 'Warp Speed' Plan?

The unveiling of US president Donald Trump’s 'Warp Speed’ plan to fast-track a coronavirus vaccine and the latest promising Phase I data from Moderna's candidate haven't seemed to swing China’s belief that it’s still leading the race.

Coronavirus COVID-19 China

China, US Carve Own Paths But Physicians Urge Collaboration With Vaccines Years Away

Despite different approaches, top virologists and renowned front-line physicians from China and the US see the need to share clinical experiences and for global cooperation on treatments and vaccines as economies start re-opening amid fear of a second wave. 

Coronavirus COVID-19 Research & Development
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Genetronics Biomedical Ltd.
  • Genetronics Biomedical Corp.
  • Inovio Biomedical Corp.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Inovio Pharmaceuticals Inc.
  • Senior Management
  • J. Joseph Kim, PhD, Pres. & CEO
    Peter Kies, CFO
    Laurent Humeau, PhD, CSO
    Jacqueline E Shea, PhD, EVP, COO
  • Contact Info
  • Inovio Pharmaceuticals Inc.
    Phone: (267) 440-4200
    660 West Germantown Pike
    Ste. 110
    Plymouth Meeting, PA 19462
    USA
UsernamePublicRestriction

Register